The DOI matches its Crossref record; 2,576 of the 2,576 references it cites were found in a registry or an index.
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
Open accessAbstract
Many physiologic effects of l-glutamate, the major excitatory neurotransmitter in the mammalian central nervous system, are mediated via signaling by ionotropic glutamate receptors (iGluRs). These ligand-gated ion channels are critical to brain function and are centrally implicated in numerous psychiatric and neurologic disorders. There are different classes of iGluRs with a variety of receptor subtypes in each class that play distinct roles in neuronal functions. The diversity in iGluR subtypes, with their unique functional properties and physiologic roles, has motivated a large number of studies. Our understanding of receptor subtypes has advanced considerably since the first iGluR subunit gene was cloned in 1989, and the research focus has expanded to encompass facets of biology that have been recently discovered and to exploit experimental paradigms made possible by technological advances. Here, we review insights from more than 3 decades of iGluR studies with an emphasis on the progress that has occurred in the past decade. We cover structure, function, pharmacology, roles in neurophysiology, and therapeutic implications for all classes of receptors assembled from the subunits encoded by the 18 ionotropic glutamate receptor genes. SIGNIFICANCE STATEMENT: Glutamate receptors play important roles in virtually all aspects of brain function and are either involved in mediating some clinical features of neurological disease or represent a therapeutic target for treatment. Therefore, understanding the structure, function, and pharmacology of this class of receptors will advance our understanding of many aspects of brain function at molecular, cellular, and system levels and provide new opportunities to treat patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“NMDARs are heterotetrameric ligand-gated ionotropic receptors”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Hansen et al., 2021
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 2,201–2,400 of 2,576
Kleckner, N. W., & Pallotta, B. S. (1995) · The Journal of Physiology · doi:10.1113/jphysiol.1995.sp020822 · Cited by 27
α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Antagonists: From Bench to Bedside
Mattes, H., Carcache, D. A., Kalkman, H. O., & Koller, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901688m · Cited by 27
Bowie, D., & Smart, T. G. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13642.x · Cited by 27
Self-citationCyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonists
Nguyen, K. T., Claiborne, C. F., McCauley, J. A., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.04.084 · Cited by 27
Poulsen, M. H., Lucas, S., Bach, T. B., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301602d · Cited by 27
Vernon, C. G., & Swanson, G. T. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.2978-16.2017 · Cited by 27
Self-citationHernandez, A. R., & Furukawa, H. (2017) · Molecular Pharmacology · doi:10.1124/mol.116.107912 · Cited by 27
Self-citationJäck, A., Hamad, M. I. K., Gonda, S., Gralla, S., Pahl, S., Hollmann, M., & Wahle, P. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1414-0 · Cited by 27
Marwick, K. F. M., Hansen, K. B., Skehel, P., Hardingham, G. E., & Wyllie, D. J. A. (2019) · The Journal of Physiology · doi:10.1113/jp277292 · Cited by 27
Self-citationAlexander, R. P. D., Mitry, J., Sareen, V., Khadra, A., & Bowie, D. (2019) · eNeuro · doi:10.1523/eneuro.0126-19.2019 · Cited by 27
Self-citationDittmer, P. J., Dell’Acqua, M. L., & Sather, W. A. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902461116 · Cited by 27
Self-citationNeuronal Glutamatergic Synaptic Clefts Alkalinize Rather Than Acidify during Neurotransmission
Stawarski, M., Hernandez, R. X., Feghhi, T., Borycz, J. A., Lu, Z., Agarwal, A. B., Reihl, K. D., Tavora, R., Lau, A. W. C., Meinertzhagen, I. A., et al. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1774-19.2020 · Cited by 27
Epplin, M. P., Mohan, A., Harris, L. D., Zhu, Z., Strong, K. L., Bacsa, J., Le, P., Menaldino, D. S., Traynelis, S. F., & Liotta, D. C. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01733 · Cited by 27
Self-citationSchmid, S. M., Körber, C., Herrmann, S., Werner, M., & Hollmann, M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3175-07.2007 · Cited by 26
Enantiomeric Propanolamines as selectiveN-Methyl- d -aspartate 2B Receptor Antagonists
Tahirovic, Y. A., Geballe, M. T., Gruszecka‐Kowalik, E., Myers, S. J., Lyuboslavsky, P. N., Le, P., French, A. M., Irier, H. A., Choi, W., Easterling, K. W., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8002153 · Cited by 26
Self-citationKatz, D. M., Menniti, F. S., & Mather, R. J. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.03.1045 · Cited by 26
Self-citationAdla, S. K., Slavı́ková, B., Šmídková, M., Tloušťová, E., Svoboda, M., Vyklický, V., Krausová, B. H., Hubálková, P., Nekardová, M., Holubová, K., et al. (2016) · Steroids · doi:10.1016/j.steroids.2016.08.010 · Cited by 26
Aberrant alternative splicing pattern of ADAR2 downregulates adenosine-to-inosine editing in glioma
LI, Z., Tian, Y., Tian, N., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.3907 · Cited by 26
Increased Exon 5 Expression Alters Extrasynaptic NMDA Receptors in Cerebellar Neurons
Prybylowski, K., Rumbaugh, G., Wolfe, B. B., & Vicini, S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751140.x · Cited by 26
Goldberg‐Stern, H., Ganor, Y., Cohen, R., Pollak, L., Teichberg, V. I., & Levite, M. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.11.007 · Cited by 26
Rebola, N., Sachidhanandam, S., Perrais, D., Cunha, R. A., & Mulle, C. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5182-06.2007 · Cited by 26
Effect of Ifenprodil on GluN1/GluN2B N-Methyl-D-aspartate Receptor Gating
Bhatt, J. M., Prakash, A., Suryavanshi, P. S., & Dravid, S. M. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.080952 · Cited by 26
Kinetic Contributions to Gating by Interactions Unique to N-methyl-d-aspartate (NMDA) Receptors
Borschel, W. F., Cummings, K. A., Tindell, L. K., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.678656 · Cited by 26
Subtype-Specific Agonists for NMDA Receptor Glycine Binding Sites
Maolanon, A. R., Risgaard, R., Wang, S., Snoep, Y., Papangelis, A., Yi, F., Holley, D. C., Barslund, A. F., Svenstrup, N., Hansen, K. B., et al. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00117 · Cited by 26
Self-citationJessen, M., Frederiksen, K., Yi, F., Clausen, R. P., Hansen, K. B., Bräuner‐Osborne, H., Kilburn, P., & Damholt, A. B. (2017) · Molecular Pharmacology · doi:10.1124/mol.117.108944 · Cited by 26
Self-citationAli, Z., Zulfiqar, S., Klar, J., et al. (2017) · BMC Medical Genetics · doi:10.1186/s12881-017-0504-6 · Cited by 26
Sitzia, G., Mantas, I., Zhang, X., Svenningsson, P., & Chergui, K. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108136 · Cited by 26
Activity Dependent Inhibition of AMPA Receptors by Zn 2+
Carrillo, E. C., Bhatia, N. K., Akimzhanov, A. M., & Jayaraman, V. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1481-20.2020 · Cited by 26
Self-citationNMDA Receptors Require Multiple Pre-opening Gating Steps for Efficient Synaptic Activity
Amin, J. B., Gochman, A., He, M., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.11.009 · Cited by 26
Extracellular Vestibule Determinants of Ca2+ Influx in Ca2+‐Permeable AMPA Receptor Channels
Jatzke, C., Hernandez, M., & Wollmuth, L. P. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2002.034413 · Cited by 25
Self-citationSchneggenburger, R. (1998) · Biophysical Journal · doi:10.1016/s0006-3495(98)77889-0 · Cited by 25
Mancini, J., & Atchison, W. D. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.09.079 · Cited by 25
Torashima, T., Iizuka, A., Horiuchi, H., Mitsumura, K., Yamasaki, M., Koyama, C., Takayama, K., Iino, M., Watanabe, M., & Hirai, H. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06841.x · Cited by 25
Glutamate delta-1 receptor regulates cocaine-induced plasticity in the nucleus accumbens
Liu, J., Gandhi, P. J., Pavuluri, R., Shelkar, G. P., & Dravid, S. M. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0273-9 · Cited by 25
Ishii, T., Stolz, J. R., & Swanson, G. T. (2020) · Molecular Pharmacology · doi:10.1124/mol.119.118554 · Cited by 25
Self-citationCharacterizing the binding and function of TARP γ8-selective AMPA receptor modulators
Dohrke, J.-N., Watson, J. F., Birchall, K., & Greger, I. H. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014135 · Cited by 25
Self-citationFisher, J. L. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.018 · Cited by 25
Brown, D. G., Maier, D. L., Sylvester, M. A., Hoerter, T. N., Menhaji‐Klotz, E., Lasota, C. C., Hirata, L. T., Wilkins, D. E., Scott, C. W., Trivedi, S., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.03.117 · Cited by 25
Alushin, G. M., Jane, D. E., & Mayer, M. L. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.06.002 · Cited by 25
Kawata, S., Miyazaki, T., Yamazaki, M., Mikuni, T., Yamasaki, M., Hashimoto, K., Watanabe, M., Sakimura, K., & Kano, M. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.014 · Cited by 25
Presynaptic AMPA receptors: more than just ion channels?
Schenk, U. (2004) · Biology of the Cell · doi:10.1016/j.biolcel.2004.01.008 · Cited by 25
Attenuated Plasticity of Postsynaptic Kainate Receptors in Hippocampal CA3 Pyramidal Neurons
Ito, K., Contractor, A., & Swanson, G. T. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1302-04.2004 · Cited by 25
Self-citationKask, K., Jerecı̀ć, J., Zamanillo, D., Wilbertz, J. H., Sprengel, R., & Seeburg, P. H. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02599-3 · Cited by 25
Cai, S. X. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606776894465 · Cited by 25
Disruption of cerebellar microzonal organization in GluD2 (GluRδ2) knockout mouse
Hashizume, M., Miyazaki, T., Sakimura, K., et al. (2013) · Frontiers in Neural Circuits · doi:10.3389/fncir.2013.00130 · Cited by 25
Ho15J—A new hotfoot allele in a hot spot in the gene encoding the δ2 glutamate receptor
Motohashi, J., Kakegawa, W., & Yuzaki, M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.068 · Cited by 25
Quantifying Water-Mediated Protein–Ligand Interactions in a Glutamate Receptor: A DFT Study
Sahai, M., & Biggin, P. (2011) · Journal of Physical Chemistry B · doi:10.1021/jp200776t · Cited by 25
Gating reaction mechanism of neuronal NMDA receptors
Borschel, W. F., Myers, J. M., Kasperek, E. M., Smith, T. P., Graziane, N., Nowak, L. M., & Popescu, G. (2012) · Journal of Neurophysiology · doi:10.1152/jn.00551.2012 · Cited by 25
Wen, W., Lin, C.-Y., & Niu, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-13233-2 · Cited by 25
Falcón‐Moya, R., Losada-Ruiz, P., Sihra, T. S., & Moreno, A. R. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00195 · Cited by 25
PTC-174, a positive allosteric modulator of NMDA receptors containing GluN2C or GluN2D subunits
Yi, F., Rouzbeh, N., Hansen, K. B., Xu, Y., Fanger, C. M., Gordon, E., Paschetto, K. A., Menniti, F. S., & Volkmann, R. A. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107971 · Cited by 25
Self-citationSzakács, R., Janka, Z., & Kálmán, J. (2012) · PubMed · doi:10.5706/nph201203003 · Cited by 24
The Selective Activation of the Glutamate Receptor GluR5 by ATPA Is Controlled by Serine 741
Nielsen, M. M., Liljefors, T., Krogsgaard‐Larsen, P., & Egebjerg, J. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.1.19 · Cited by 24
Michishita, M., Ikeda, T., Nakashiba, T., Ogawa, M., Tashiro, K., Honjo, T., Doi, K., Itohara, S., & Endo, S. (2004) · Developmental Brain Research · doi:10.1016/j.devbrainres.2004.06.012 · Cited by 24
Two serine residues on GluN2A C-terminal tails control NMDA receptor current decay times
Maki, B. A., Cole, R., & Popescu, G. (2013) · Channels · doi:10.4161/chan.23968 · Cited by 24
Niemann, S., Landers, J. E., Churchill, M., Hosler, B. A., Sapp, P. C., Speed, W. C., Lahn, B. T., Kídd, K. K., Brown, R. H., & Hayashi, Y. (2007) · Neurology · doi:10.1212/01.wnl.0000271078.51280.17 · Cited by 24
Modulation of ionotropic glutamate receptor function by vertebrate galectins
Copits, B. A., Vernon, C. G., Sakai, R., et al. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2013.269597 · Cited by 24
Partial deletion of GLRB and GRIA2 in a patient with intellectual disability
Hackmann, K., Matko, S., Gerlach, E., von der Hagen, M., Klink, B., Schröck, E., Rump, A., & Donato, N. D. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.97 · Cited by 24
Layton, M. E., Kelly, M. J., Rodzinak, K. J., Sanderson, P. E. J., Young, S. D., Bednar, R. A., DiLella, A. G., McDonald, T. P., Wang, H., Mosser, S. D., et al. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200013d · Cited by 24
Exploring kainate receptor pharmacology using molecular dynamics simulations
Postila, P. A., Swanson, G. T., & Pentikäinen, O. T. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.08.019 · Cited by 24
Self-citationMonnerie, H., & Roux, P. D. L. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20805 · Cited by 24
Juknaitė, L., Sugamata, Y., Tokiwa, K., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301590z · Cited by 24
Frølund, S., Bella, A., Kristensen, A. S., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100886h · Cited by 24
Mesbahi‐Vasey, S., Veras, L., Yonkunas, M. J., Johnson, J. W., & Kurnikova, M. G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177686 · Cited by 24
Herring, W. J., Assaid, C. A., Budd, K., Vargo, R. C., Mazenko, R. S., Lines, C., Ellenbogen, A. L., & Metman, L. V. (2017) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000241 · Cited by 24
RNAi-Based GluN3A Silencing Prevents and Reverses Disease Phenotypes Induced by Mutant huntingtin
Marco, S., Murillo, A., & Pérez‐Otaño, I. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.05.013 · Cited by 24
Mechanisms of CPT1C-Dependent AMPAR Trafficking Enhancement
Gratacòs‐Batlle, E., Olivella, M., Sánchez-Fernández, N., Yefimenko, N., Míguez‐Cabello, F., Fadó, R., Casals, N., Gasull, X., Ambrosio, S., & Soto, D. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00275 · Cited by 24
The NMDA receptor intracellular C-terminal domains reciprocally interact with allosteric modulators
Sapkota, K., Doré, K., Tang, K. L., Irvine, M. W., Fang, G., Burnell, E. S., Malinow, R., Jane, D. E., & Monaghan, D. T. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.11.018 · Cited by 24
Modulation of TARP γ8–Containing AMPA Receptors as a Novel Therapeutic Approach for Chronic Pain
Knopp, K. L., Simmons, R. M. A., Guo, W., Adams, B. L., Gardinier, K. M., Gernert, D. L., Ornstein, P. L., Porter, W. J., Reel, J. K., Ding, C., et al. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.250126 · Cited by 24
Mutational Analysis and Modeling of Negative Allosteric Modulator Binding Sites in AMPA Receptors
Stenum-Berg, C., Musgaard, M., Chavez-Abiega, S., et al. (2019) · Molecular Pharmacology · doi:10.1124/mol.119.116871 · Cited by 24
Perszyk, R. E., Myers, S. J., Yuan, H., Gibb, A. J., Furukawa, H., Sobolevsky, A. I., & Traynelis, S. F. (2020) · The Journal of Physiology · doi:10.1113/jp278086 · Cited by 24
Self-citationKamalova, A., Futai, K., Delpire, E. J., & Nakagawa, T. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107921 · Cited by 24
Self-citationLiu, J., Shelkar, G. P., Sarode, L. P., Gawande, D. Y., Zhao, F., Clausen, R. P., Ugale, R. R., & Dravid, S. M. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105254 · Cited by 24
Pharmacology of NMDA receptors
JANE, D. (2001) · CRC Press eBooks · doi:10.1201/9780203299388-7 · Cited by 23
pH-Sensitive NMDA Inhibitors Improve Outcome in a Murine Model of SAH
Wang, H., James, M. L., Venkatraman, T. N., Wilson, L. J., Lyuboslavsky, P. N., Myers, S. J., Lascola, C. D., & Laskowitz, D. T. (2014) · Neurocritical Care · doi:10.1007/s12028-013-9944-9 · Cited by 23
Gill, M., Frausto, S. F., Ikoma, M., Sasaki, M., Oikawa, M., Sakai, R., & Swanson, G. T. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00784.x · Cited by 23
Self-citationDaniels, B. A., Andrews, E. D., Aurousseau, M. R. P., et al. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.253666 · Cited by 23
Negrete‐Díaz, J. V., Duque‐Feria, P., Andrade‐Talavera, Y., Carrión, M., Flores, G., & Moreno, A. R. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07665.x · Cited by 23
Yamazaki, M., Pichon, C. E. L., Jackson, A. C., Cerpas, M., Sakimura, K., Scearce-Levie, K. A., & Nicoll, R. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423670112 · Cited by 23
Venskutonytė, R., Butini, S., Coccone, S. S., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2004078 · Cited by 23
Prithviraj, R., & Inglis, F. M. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.03.089 · Cited by 23
Madsen, U., Frydenvang, K., Ebert, B., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950393q · Cited by 23
Distribution of the NMDA receptor NR3A subunit in the adult pig-tail macaque brain
Mueller, H. T., & Meador‐Woodruff, J. H. (2004) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2004.11.002 · Cited by 23
Conti, P., Pinto, A., Tamborini, L., et al. (2010) · ChemMedChem · doi:10.1002/cmdc.201000184 · Cited by 23
Ganor, Y., Goldberg‐Stern, H., Blank, M., Shoenfeld, Y., Добрынина, Л. А., Kalashnikova, L. A., & Levite, M. (2005) · Autoimmunity · doi:10.1080/08916930500246339 · Cited by 23
Sakha, P., Vesikansa, A., Orav, E., et al. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00003 · Cited by 23
Gan, Q., Dai, J., Zhou, H., & Wollmuth, L. P. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.686246 · Cited by 23
Self-citationDuan, G., Ye, Y., Xu, S., Tao, W., Zhao, S., Jin, T., Nicoll, R. A., Shi, Y. S., & Sheng, N. (2018) · Nature Communications · doi:10.1038/s41467-018-07403-7 · Cited by 23
Auxiliary subunits keep AMPA receptors compact during activation and desensitization
Baranovic, J., & Plested, A. J. R. (2018) · eLife · doi:10.7554/elife.40548 · Cited by 23
Pereira, V. S., Joca, S. R. L., Harvey, B. H., Elfving, B., & Wegener, G. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2019.25 · Cited by 23
A primate-specific short GluN2A-NMDA receptor isoform is expressed in the human brain
Warming, H., Pegasiou, C.-M., Pitera, A. P., Kariis, H. M., Houghton, S. D., Kurbatskaya, K., Ahmed, A. I., Grundy, P., Vajramani, G., Bulters, D. O., et al. (2019) · Molecular Brain · doi:10.1186/s13041-019-0485-9 · Cited by 23
Peter, S., Urbanus, B. H. A., Klaassen, R. V., Wu, B., Boele, H., Azizi, S., Slotman, J. A., Houtsmuller, A. B., Schonewille, M., Hoebeek, F. E., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.03.079 · Cited by 23
Piard, J., Béreau, M., XiangWei, W., Wirth, T., Amsallem, D., Buisson, L., Richard, P., Liu, N., Xu, Y., Myers, S. J., et al. (2020) · Movement Disorders · doi:10.1002/mds.28058 · Cited by 23
Self-citationPresynaptic AMPA receptors: more than just ion channels?
Schenk, U., & Matteoli, M. (2004) · Biology of the Cell · doi:10.1111/j.1768-322x.2004.tb01413.x · Cited by 23
N-Hydroxypyrazolyl Glycine Derivatives as SelectiveN-Methyl- d -aspartic Acid Receptor Ligands
Clausen, R. P., Christensen, C. E., Hansen, K. B., Greenwood, J. R., Micale, N., Madsen, J. C., Nielsen, B., Egebjerg, J., Bräuner‐Osborne, H., Traynelis, S. F., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800025e · Cited by 22
Self-citationMolecular Determinants of Glycine-Independent Desensitization of NR1/NR2A Receptors
Hu, B., & Zheng, F. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.080168 · Cited by 22
MAP1B binds to the NMDA receptor subunit NR3A and affects NR3A protein concentrations
Eriksson, M., Samuelsson, H., Björklund, S., Tortosa, E., Ávila, J., Samuelsson, E., Benedikz, E., & Sundström, E. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.03.039 · Cited by 22
Wee, K. S.-L., Tan, F. C. K., Cheong, Y. P., et al. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1794-8 · Cited by 22
Unno, M., Shinohara, M., Takayama, K., et al. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.08.043 · Cited by 22
Effects of NR1 splicing on NR1/NR3B-type excitatory glycine receptors
Cavara, N. A., Orth, A., & Hollmann, M. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-32 · Cited by 22
Crystal structure of the glutamate receptor GluA1 N-terminal domain
Yao, G., Zong, Y., Gu, S., et al. (2011) · Biochemical Journal · doi:10.1042/bj20110801 · Cited by 22
Cortical G luK1 kainate receptors modulate scratching in adult mice
Descalzi, G., Chen, T., Koga, K., et al. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12351 · Cited by 22
Clausen, R. P., Hansen, K. B., Calı́, P., et al. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.049 · Cited by 22
Self-citationWest, P. J., Dalpé-Charron, A., & Wilcox, K. S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.02.035 · Cited by 22
Evaluation of PhTX-74 as Subtype-Selective Inhibitor of GluA2-Containing AMPA Receptors
Poulsen, M. H., Lucas, S., Strømgaard, K., & Kristensen, A. S. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.089961 · Cited by 22
Potentiation of glycine-gated NR1/NR3A NMDA receptors relieves Ca2+-dependent outward rectification
Madry, C. (2010) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2010.00006 · Cited by 22
Calton, J. L., Kang-Park, M.-H., Wilson, W. A., & Moore, S. D. (2000) · Journal of Neurophysiology · doi:10.1152/jn.2000.83.2.685 · Cited by 22
Keavy, D., Bristow, L. J., Sivarao, D. V., Batchelder, M., King, D., Thangathirupathy, S., Macor, J. E., & Weed, M. R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152729 · Cited by 22
Structural Determinants of the γ-8 TARP Dependent AMPA Receptor Antagonist
Lee, M. R., Gardinier, K. M., Gernert, D. L., Schober, D. A., Wright, R. A., Wang, H., Qian, Y., Witkin, J. M., Nisenbaum, E. S., & Kato, A. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00186 · Cited by 22
Neurosteroids and Oxysterols as Potential Therapeutic Agents for Glaucoma and Alzheimer’s Disease
Ishikawa, M., Yoshitomi, T., Covey, D. F., Zorumski, C. F., & Izumi, Y. (2018) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000356 · Cited by 22
NMDA Receptor Opening and Closing—Transitions of a Molecular Machine Revealed by Molecular Dynamics
Černý, J., Božíková, P., Balík, A., Marques, S. M., & Vyklický, L. (2019) · Biomolecules · doi:10.3390/biom9100546 · Cited by 22
Structural basis of AMPA receptor inhibition by trans‐4‐butylcyclohexane carboxylic acid
Yelshanskaya, M. V., Singh, A. K., Narangoda, C., Williams, R. S. B., Kurnikova, M. G., & Sobolevsky, A. I. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15254 · Cited by 22
Self-citationThree-dimensional missense tolerance ratio analysisPreprint
Perszyk, R. E., Kristensen, A. S., Lyuboslavsky, P. N., & Traynelis, S. F. (2021) · Genome Research · doi:10.1101/gr.275528.121 · Cited by 22
Self-citationDomingues, A. M. D. J., Neugebauer, K. M., & Fern, R. F. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07212.x · Cited by 21
Open-channel blockade is less effective on GluN3B than GluN3A subunit-containing NMDA receptors
McClymont, D. W., Harris, J. E., & Mellor, I. R. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.04.036 · Cited by 21
Poluch, S., & König, N. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02068.x · Cited by 21
Liu, H., Wang, H., Peterson, M., Zhang, W., Hou, G., & Zhang, Z. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1905721116 · Cited by 21
Wang, A. L., Carroll, R. C., & Nawy, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091288 · Cited by 21
Venskutonytė, R., Frydenvang, K., Gajhede, M., et al. (2011) · Journal of Structural Biology · doi:10.1016/j.jsb.2011.08.014 · Cited by 21
Jensen, L. S., Bølcho, U., Egebjerg, J., et al. (2006) · ChemMedChem · doi:10.1002/cmdc.200500093 · Cited by 21
Cell proliferation in the brains of NMDAR NR1 transgenic mice
Bursztajn, S., Falls, W. A., Berman, S. A., et al. (2007) · Brain Research · doi:10.1016/j.brainres.2007.07.045 · Cited by 21
The Role of NMDA Receptor Subtypes in Short-Term Plasticity in the Rat Entorhinal Cortex
Chamberlain, S. E. L., Yang, J. F., & Jones, R. S. G. (2008) · Neural Plasticity · doi:10.1155/2008/872456 · Cited by 21
Jouhanneau, J.-S., Ball, S. M., Molnár, E., & Isaac, J. T. R. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.12.023 · Cited by 21
Griffith, T. N., & Swanson, G. T. (2015) · The Journal of Physiology · doi:10.1113/jp271103 · Cited by 21
Self-citationGallimore, A., Aricescu, A., Yuzaki, M., & Calinescu, R. (2016) · PLoS Comput. Biol. · doi:10.1371/journal.pcbi.1004664 · Cited by 21
Ionotropic glutamate receptor expression in human white matter
Christensen, P. C., Samadi‐Bahrami, Z., Pavlov, V., Stys, P. K., & Moore, G. R. W. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.07.030 · Cited by 21
Semiclosed Conformations of the Ligand-Binding Domains of NMDA Receptors during Stationary Gating
Dai, J., & Zhou, H. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2016.08.010 · Cited by 21
Mechanism of partial agonism in AMPA-type glutamate receptors
Salazar, H., Eibl, C., Chebli, M., & Plested, A. J. R. (2017) · Nature Communications · doi:10.1038/ncomms14327 · Cited by 21
Wei, M., Jia, M., Zhang, J., Yu, L., Zhao, Y., Chen, Y., Ma, Y., Zhang, W., Shi, Y. S., & Zhang, C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00055 · Cited by 21
Strong, K. L., Epplin, M. P., Bacsa, J., Butch, C. J., Burger, P. B., Menaldino, D. S., Traynelis, S. F., & Liotta, D. C. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00239 · Cited by 21
Self-citationLee, J. Y., Krieger, J., Herguedas, B., García‐Nafría, J., Dutta, A., Shaikh, S. A., Greger, I. H., & Bahar, İ. (2018) · Structure · doi:10.1016/j.str.2018.10.017 · Cited by 21
Self-citationPollok, S., & Reiner, A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2007471117 · Cited by 21
Localization and Functions of Kainate Receptors in the Basal Ganglia
Jin, X., & Smith, Y. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9557-5_3 · Cited by 20
Schober, D. A., Gill, M. B., Yu, H. Y., Gernert, D. L., Jeffries, M. W., Ornstein, P. L., Kato, A., Felder, C. C., & Bredt, D. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.212522 · Cited by 20
NR3 protein expression in trigeminal neurons during postnatal development
Ishihama, K., & Turman, J. E. (2006) · Brain Research · doi:10.1016/j.brainres.2006.04.010 · Cited by 20
Das, S. R., Jensen, R., Kelsay, R., Shumaker, M., Bochart, R. M., Brim, B., Zamzow, D. R., & Magnusson, K. R. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.02.014 · Cited by 20
Mahmoud, H., Martin, N., & Hildebrand, M. E. (2020) · Molecular Brain · doi:10.1186/s13041-020-00566-9 · Cited by 20
Krintel, C., Harpsøe, K., Zachariassen, L. G., et al. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444913011839 · Cited by 20
Tzschach, A., Menzel, C., Erdogan, F., Istıflı, E. S., Rieger, M., Ovens‐Raeder, A., Macke, A., Ropers, H., Ullmann, R., & Kalscheuer, V. M. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33343 · Cited by 20
Elimination of Redundant Synaptic Inputs in the Absence of Synaptic Strengthening
Wang, H., Liu, H., & Zhang, Z. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4569-11.2011 · Cited by 20
Irvine, M. W., Costa, B. M., Dlaboga, D., Culley, G. R., Hulse, R. P., Scholefield, C. L., Atlason, P. T., Fang, G., Eaves, R. J., Morley, R., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201230z · Cited by 20
Clausen, R. P., Naur, P., Kristensen, A. S., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900565c · Cited by 20
Facilitation of neocortical presynaptic terminal development by NMDA receptor activation
Sceniak, M. P., Berry, C. T., & Sabo, S. L. (2012) · Neural Development · doi:10.1186/1749-8104-7-8 · Cited by 20
Seifi, M., & Swinny, J. D. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12768 · Cited by 20
Bettler, B., & Fakler, B. (2017) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2017.02.011 · Cited by 20
Tapken, D., Steffensen, T. B., Leth, R., Kristensen, L. B., Gerbola, A., Gajhede, M., Jørgensen, F. S., Olsen, L., & Kastrup, J. S. (2017) · Scientific Reports · doi:10.1038/srep46145 · Cited by 20
Energetics of Glutamate Binding to an Ionotropic Glutamate Receptor
Yu, A., & Lau, A. Y. (2017) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.7b06862 · Cited by 20
Activity‐dependent control of NMDA receptor subunit composition at hippocampal mossy fibre synapses
Carta, M., Srikumar, B. N., Gorlewicz, A., Rebola, N., & Mulle, C. (2017) · The Journal of Physiology · doi:10.1113/jp275226 · Cited by 20
Kaiser, T. M., Kell, S. A., Kusumoto, H., et al. (2017) · Molecular Pharmacology · doi:10.1124/mol.117.110940 · Cited by 20
Marcelli, S., Iannuzzi, F., Ficulle, E., Mango, D., Pieraccini, S., Pellegrino, S., Corbo, M., Sironi, M., Pittaluga, A., Nisticò, R., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-43709-2 · Cited by 20
La, D. S., Salituro, F. G., Botella, G. M., Griffin, A. M., Bai, Z., Ackley, M. A., Dai, J., Doherty, J., Harrison, B. L., Hoffmann, E. C., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00591 · Cited by 20
Kumari, J., Bendre, A. D., Bhosale, S., et al. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.01.282 · Cited by 20
Chen, X., Keramidas, A., Harvey, V. L., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104850 · Cited by 20
Emerging drugs for the treatment of L-DOPA-induced dyskinesia: an update
Alshimemeri, S. A., Fox, S. H., & Visanji, N. P. (2020) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2020.1763954 · Cited by 20
Skřenková, K., Song, J., Kortus, Š., Kolcheva, M., Netolický, J., Hemelíková, K., Kaniaková, M., Krausová, B. H., Kucera, T., Korábečný, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-75646-w · Cited by 20
Yozu, M., Tabata, H., König, N., & Nakajima, K. (2007) · Developmental Neuroscience · doi:10.1159/000109856 · Cited by 19
Modal gating of GluN1/GluN2D NMDA receptors
Vance, K. M., Hansen, K. B., & Traynelis, S. F. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.018 · Cited by 19
Self-citationA GRIK4 variant conferring protection against bipolar disorder modulates hippocampal function
Whalley, H. C., Pickard, B. S., McIntosh, A. M., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.7 · Cited by 19
Krogsgaard‐Larsen, N., Storgaard, M., Møller, C. T., Demmer, C. S., Hansen, J. K., Han, L., Monrad, R. N., Nielsen, B., Tapken, D., Pickering, D. S., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00750 · Cited by 19
Watanabe, C., Orito, T., Watanabe, H., et al. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.027 · Cited by 19
Larsen, A. M., Venskutonytė, R., Valadés, E. A., et al. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100093f · Cited by 19
Wilding, T. J., Chen, K., & Huettner, J. E. (2010) · The Journal of General Physiology · doi:10.1085/jgp.201010442 · Cited by 19
Chen, H.-Y., & Chesler, M. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2293-14.2015 · Cited by 19
A novel class of negative allosteric modulators of NMDA receptor function
Katzman, B. M., Perszyk, R. E., Yuan, H., et al. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.10.046 · Cited by 19
Self-citationImpact of calcium-activated potassium channels on NMDA spikes in cortical layer 5 pyramidal neurons
Bock, T., & Stuart, G. J. (2016) · Journal of Neurophysiology · doi:10.1152/jn.01047.2015 · Cited by 19
Kapadia, M., Bijelić, D. D., Zhao, H., Ma, D., Stojanovich, L., Milosevic, M. M., Anđjus, P. R., & Šakić, B. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0473-1 · Cited by 19
Wells, G., Yuan, H., McDaniel, M. J., et al. (2018) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25595 · Cited by 19
Self-citationSavall, B. M., Wu, D., Swanson, D. M., Seierstad, M. J., Wu, N., Martinez, J. V., Olmos, B. G., Lord, B., Coe, K. J., Koudriakova, T. B., et al. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00599 · Cited by 19
Measurements of the Timescale and Conformational Space of AMPA Receptor Desensitization
Salazar, H., Mischke, S., & Plested, A. J. R. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2020.05.029 · Cited by 19
Palmitoylation Controls NMDA Receptor Function and Steroid Sensitivity
Hubálková, P., Ladislav, M., Vyklický, V., Smejkalová, T., Krausová, B. H., Kysilov, B., Krůšek, J., Naimová, Ž., Kořı́nek, M., Chodounská, H., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2654-20.2021 · Cited by 19
Binding of ArgTX-636 in the NMDA Receptor Ion Channel
Poulsen, M. H., Andersen, J., Christensen, R. H., Hansen, K. B., Traynelis, S. F., Strømgaard, K., & Kristensen, A. S. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.05.017 · Cited by 18
Self-citationMauric, V., Mölders, A., Harmel, N., Heimrich, B., Sergeeva, O. A., & Klöcker, N. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.02.001 · Cited by 18
Characteristics of Gait Ataxia in δ2 Glutamate Receptor Mutant Mice, ho15J
Takeuchi, E., Sato, Y., Miura, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047553 · Cited by 18
Anions Mediate Ligand Binding in Adineta vaga Glutamate Receptor Ion Channels
Lomash, S., Chittori, S., Brown, P., et al. (2013) · Structure · doi:10.1016/j.str.2013.01.006 · Cited by 18
Gowd, K. H., Han, T., Twede, V., et al. (2012) · Biochemistry · doi:10.1021/bi300055n · Cited by 18
A novel series of benzimidazole NR2B-selective NMDA receptor antagonists
Davies, D. J., Crowe, M., Lucas, N., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.01.108 · Cited by 18
Activity-Dependent Upregulation of Presynaptic Kainate Receptors at Immature CA3–CA1 Synapses
Clarke, V. R. J., Molchanova, S. M., Hirvonen, T., Taira, T., & Lauri, S. E. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1842-14.2014 · Cited by 18
Gelsomino, G., Menna, E., Antonucci, F., Rodighiero, S., Riganti, L., Mulle, C., Benfenati, F., Valtorta, F., Verderio, C., & Matteoli, M. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhs026 · Cited by 18
Tao-Cheng, J.-H., Azzam, R. N., Crocker, V. T., Winters, C. A., & Reese, T. S. (2015) · eNeuro · doi:10.1523/eneuro.0066-15.2015 · Cited by 18
Demmer, C. S., Møller, C. T., Brown, P. M. G. E., Han, L., Pickering, D. S., Nielsen, B., Bowie, D., Frydenvang, K., Kastrup, J. S., & Bunch, L. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00038 · Cited by 18
Self-citationEndogenous NMDA-Receptor Activation Regulates Glutamate Release in Cultured Spinal Neurons
Robert, A., Black, J. A., & Waxman, S. G. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.1.196 · Cited by 18
Yang, Y., Yuan, C., Shen, S., Wang, X.-E., Mei, Q., Jiang, W.-Q., & Huang, Q. (2017) · Mediators of Inflammation · doi:10.1155/2017/5047898 · Cited by 18
N‐glycan content modulates kainate receptor functional properties
Vernon, C. G., Copits, B. A., Stolz, J. R., Guzmán, Y. F., & Swanson, G. T. (2017) · The Journal of Physiology · doi:10.1113/jp274790 · Cited by 18
Self-citationDemmer, C. S., Rombach, D., Liu, N., et al. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00243 · Cited by 18
Bristow, L. J., Gulia, J., Weed, M. R., Srikumar, B. N., Li, Y.-W., Graef, J. D., Naidu, P. S., Sanmathi, C., Aher, J., Bastia, T., et al. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.242784 · Cited by 18
Brogi, S., Brindisi, M., Butini, S., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00099 · Cited by 18
Gao, J., Hu, X., Yang, H. S., & Xia, H. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0886-2 · Cited by 18
Marcin, L. R., Warrier, J., Thangathirupathy, S., Shi, J., Karageorge, G. N., Pearce, B. C., Ng, A., Park, H., Kempson, J., Li, J., et al. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00080 · Cited by 18
The C-terminus of NMDAR GluN1-1a Subunit Translocates to Nucleus and Regulates Synaptic Function
Zhou, L., & Duan, J. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00334 · Cited by 18
Morris, P. G., Mishina, M., & Jones, S. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00354 · Cited by 18
Noncompetitive antagonists induce cooperative AMPA receptor channel gating
Shi, E. Y., Yuan, C. L., Sipple, M. T., Srinivasan, J., Ptak, C. P., Oswald, R. E., & Nowak, L. M. (2019) · The Journal of General Physiology · doi:10.1085/jgp.201812209 · Cited by 18
Lectins modulate the functional properties of GluN1/GluN3-containing NMDA receptors
Hemelíková, K., Kolcheva, M., Skřenková, K., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107671 · Cited by 18
Moldavski, A., Behr, J., Bading, H., & Bengtson, C. P. (2019) · The Journal of Physiology · doi:10.1113/jp278362 · Cited by 18
Sager, C., Terhag, J., Kott, S., & Hollmann, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.039891 · Cited by 17
Semenov, A., Möykkynen, T. P., Coleman, S. K., Korpi, E. R., & KEINÄNEN, K. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049282 · Cited by 17
Kainate induces various domain closures in AMPA and kainate receptors
Venskutonytė, R., Frydenvang, K., Hald, H., et al. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.02.016 · Cited by 17
Ito, A., Kakegawa, W., Kohda, K., Miura, E., Okabe, S., & Yuzaki, M. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12487 · Cited by 17
Amino Acid Substitutions in the Pore Helix of GluR6 Control Inhibition by Membrane Fatty Acids
Wilding, T. J., Fulling, E., Zhou, Y., & Huettner, J. E. (2008) · The Journal of General Physiology · doi:10.1085/jgp.200810009 · Cited by 17
Nuedexta for the treatment of pseudobulbar affect: a condition of involuntary crying or laughing.
Cruz, M. P. (2013) · PubMed · Cited by 17
Agonist-specific gating of NMDA receptors
Kussius, C. L., Popescu, A. M., & Popescu, G. (2010) · Channels · doi:10.4161/chan.4.2.10523 · Cited by 17
Flagged first, then by citations
Cited by
Sorted by citations
Mechanisms of ketamine and its metabolites as antidepressants
Hess, E. M., Riggs, L. M., Michaelides, M., & Gould, T. D. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114892 · Cited by 175
Coombs, I. D., Ziobro, J., Krotov, V., Surtees, T., Cull‐Candy, S. G., & Farrant, M. (2022) · Epilepsia · doi:10.1111/epi.17419 · Cited by 32
Cryo-EM structure of the human Asc-1 transporter complex
Li, Y., Guo, Y., Bröer, A., Dai, L., Brӧer, S., & Yan, R. (2024) · Nature Communications · doi:10.1038/s41467-024-47468-1 · Cited by 12
Glutamate receptor 4 as a fluid biomarker for the diagnosis of psychiatric disorders
Gómez de San José, N., Goossens, J., Al Shweiki, M. R., Halbgebauer, S., Oeckl, P., Steinacker, P., Danzer, K. M., Graf, H., Schönfeldt-Lecuona, C., Belbin, O., et al. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.10.010 · Cited by 9
Metadata
- Authors
- Hansen, K. B., Wollmuth, L. P., Bowie, D., Furukawa, H., Menniti, F. S., Sobolevsky, A. I., Swanson, G. T., Swanger, S. A., Greger, I. H., Nakagawa, T., McBain, C. J., Jayaraman, V., Low, C.-M., Dell’Acqua, M. L., Diamond, J. S., Camp, C. R., Perszyk, R. E., Yuan, H., & Traynelis, S. F.
- Affiliations
- Northwestern University (US)
- Corresponding author
- Traynelis, Stephen F.
- ORCID
- Hansen, Kasper B.
- Wollmuth, Lonnie P.
- Bowie, Derek
- Furukawa, Hiro
- Menniti, Frank S.
- Sobolevsky, Alexander I.
- Swanson, Geoffrey T.
- Swanger, Sharon A.
- Greger, Ingo H.
- Nakagawa, Terunaga
- McBain, Chris J.
- Jayaraman, Vasanthi
- Low, Chian-Ming
- Dell’Acqua, Mark L.
- Diamond, Jeffrey S.
- Camp, Chad R.
- Perszyk, Riley E.
- Yuan, Hongjie
- Traynelis, Stephen F.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2021-10
- Volume
- 73
- Issue
- 4
- Pages
- 1469-1658
- ISSN
- 0031-6997 (ISSN-L)
- PMC
- PMC8626789
- OpenAlex
- W3214054678
- Cited by
- 686
- References
- 2,576
- Citations by year
- 2026: 123 · 2025: 198 · 2024: 160 · 2023: 115 · 2022: 81 · 2021: 9
- FWCI
- 13.86
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Pharmacological Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Funders
- National Institutes of Health (5f31ns113530-02)
- Biotechnology and Biological Sciences Research Council (BB/N002113/1)
- National Institute of Mental Health (R56MH123474, R21MH127404, R01MH085926, R01MH123474)
- National Cancer Institute (R01CA206573)
- National Institute of General Medical Sciences (P20GM103546, R35GM122528)
- National Institute of Neurological Disorders and Stroke (F31‐NS113530, R01NS105804, R56NS040701, R01NS083660, R01NS040701, R01NS088479, R01NS111745, RF1NS113632, R01NS105502, R01NS107253, R35NS111619, R37NS083660, R01NS116055, R01NS097536)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD082373)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- ionotropic glutamate receptors, ligand-gated ion channels, glutamate, receptor subtypes, receptor structure, receptor pharmacology, excitatory neurotransmission, neurophysiology, neurological disorders, mental illness, therapeutic target
- MeSH terms
- Animals, Central Nervous System, Humans, Receptors, Glutamate, Neurotransmitter Agents, Glutamic Acid, Receptors, Ionotropic Glutamate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review